We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Imaging Platform Characterizes Particles Using Raman Spectroscopy

By LabMedica International staff writers
Posted on 06 Nov 2012
New imaging technology combines automated particle imaging with chemical identification of individual particles using Raman spectroscopy. More...
This automated system measures particle size, shape, and chemical identity in a single platform.

Following the completion of an effective early access program, the Morphologi G3-ID particle characterization system has been launched to the global market. The Morphologi G3-ID, developed by Malvern Instruments (Malvern, UK; www.malvern.com), is designed to unravel complicated particle characterization problems where particle size and shape do not provide adequate data. The early access program was designed to enable users to explore specific applications and to allow full optimization of the product features. Major applications for which it is establishing itself to be particularly valuable are in determining component-specific particle properties of mixtures and blends, such as the particle size of drug materials in asthma inhalers and nasal sprays, and, for instance, in the identification of unknown or suspicious particles in injectable or parenteral products.

The Morphologi G3-ID is designed to meet a wide variety of requirements and to enable all users, from particle characterization scientists with some degree of spectroscopy expertise through to experienced spectroscopists, to gain an in-depth understanding of particulate samples. Simple standard operating procedure (SOP) takes the user from integrated sample dispersion for dry powders through to shape, size, and chemical analysis, with automatic selection, targeting and chemical classification of thousands of individual particles. Measurements can be generated on dry powders, membrane filters, and suspensions.

Malvern Instruments is a developer of measuring performance-controlling material characteristics. These include particle shape and size, zeta potential, molecular weight, size, and conformation, rheologic characteristics and chemical identification. Malvern’s measurement systems for scientists, technologists, and engineers are engineered through customer collaboration. Complementary materials characterization systems provide interrelated measurements that reflect the complexities of particulates and disperse systems, macromolecules, and nanomaterials.

Related Links:

Malvern Instruments




Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Silver Member
PCR Plates
Diamond Shell PCR Plates
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.